HLNCF:OTCMKTS
Haleon PLC
$4.64
arrow_upward
+1.31%(+0.060) 1D
Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLNCF...
Open
$4.62
High
$4.64
Low
$4.62
Mkt. cap
40.27B
Avg. vol.
8.84K
Volume
3.07K
52-wk high
$5.75
52-wk low
$4.15
Beta
-21.47
Shares outstanding
8.80B
No. of employees
25K
Open
$4.62
High
$4.64
Low
$4.62
Mkt. cap
40.27B
Avg. vol.
8.84K
Volume
3.07K
52-wk high
$5.75
52-wk low
$4.15
Beta
-21.47
Shares outstanding
8.80B
No. of employees
25K
News stories
From web sources and news partners
TipRanks
·
4 hours ago
Haleon’s New Gum Health Study Signals Long-Term Upside In Oral Care
AD HOC NEWS
·
1 day ago
JPMorgan cuts target for Haleon stock to GBp 295
TipRanks
·
2 days ago
Haleon’s New Mouthwash Trial Targets Whiter Smiles And Oral Care Upside
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC